Merit Medical Systems, Inc. (MMSI)
NASDAQ: MMSI · Real-Time Price · USD
77.46
-0.56 (-0.72%)
Feb 27, 2026, 3:20 PM EST - Market open
Merit Medical Systems Stock Forecast
Stock Price Forecast
The 9 analysts that cover Merit Medical Systems stock have a consensus rating of "Strong Buy" and an average price target of $103.56, which forecasts a 33.69% increase in the stock price over the next year. The lowest target is $78 and the highest is $120.
Price Target: $103.56 (+33.69%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Merit Medical Systems stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Buy | 6 | 6 | 6 | 6 | 6 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $95 → $78 | Buy → Hold | Downgrades | $95 → $78 | +0.70% | Feb 26, 2026 |
| Barrington Research | Barrington Research | Buy Maintains $106 → $109 | Buy | Maintains | $106 → $109 | +40.72% | Feb 25, 2026 |
| Needham | Needham | Strong Buy Maintains $108 → $101 | Strong Buy | Maintains | $108 → $101 | +30.39% | Feb 25, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $113 → $106 | Buy | Maintains | $113 → $106 | +36.84% | Feb 18, 2026 |
| BTIG | BTIG | Strong Buy Initiates $107 | Strong Buy | Initiates | $107 | +38.14% | Feb 6, 2026 |
Financial Forecast
Revenue This Year
1.64B
from 1.52B
Increased by 7.99%
Revenue Next Year
1.73B
from 1.64B
Increased by 5.62%
EPS This Year
4.13
from 2.13
Increased by 93.76%
EPS Next Year
4.47
from 4.13
Increased by 8.34%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 1.7B | 1.8B | |||
| Avg | 1.6B | 1.7B | |||
| Low | 1.5B | 1.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 12.7% | 12.0% | |||
| Avg | 8.0% | 5.6% | |||
| Low | 1.8% | -1.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 4.45 | 4.79 | |||
| Avg | 4.13 | 4.47 | |||
| Low | 3.79 | 4.10 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 109.0% | 16.0% | |||
| Avg | 93.8% | 8.3% | |||
| Low | 77.8% | -0.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.